Premium
Werewolf Therapeutics Inc (HOWL)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | Institution | 6 116 140 | 12,59% | US$ 2,63M | 2026-05-12 |
| RA Capital Healthcare Fund, L.P. | Institution | 5 709 858 | 11,75% | US$ 2,46M | 2026-05-12 |
| Longwood Fund III, L.P. | Institution | 1 677 082 | 3,45% | US$ 721,15k | 2025-12-31 |
| Longwood Fund | Institution | 1 677 082 | 3,45% | US$ 721,15k | 2025-12-31 |
| Vanguard Capital Management, LLC | Institution | 1 217 976 | 2,51% | US$ 523,73k | 2026-03-31 |
| MPM BioImpact LLC | Institution | 1 171 175 | 2,41% | US$ 503,61k | 2026-05-12 |
| Dr. Luke Evnin | Initiés | 1 126 496 | 2,32% | US$ 484,39k | 2026-05-13 |
| MPM Bioventures 2014, L.P. | Institution | 845 094 | 1,74% | US$ 363,39k | 2026-05-12 |
| Lynx1 Capital Management LP | Institution | 657 786 | 1,35% | US$ 282,85k | 2026-03-31 |
| UBS Oncology Impact Fund | Institution | 655 471 | 1,35% | US$ 281,85k | 2026-05-12 |
| BioImpact Capital LLC | Institution | 655 471 | 1,35% | US$ 281,85k | 2026-05-12 |
| Dr. Daniel Hicklin | Initiés | 647 047 | 1,33% | US$ 278,23k | 2025-04-14 |
| Sphera Funds Management Ltd | Institution | 626 810 | 1,29% | US$ 269,53k | 2026-03-31 |
| DC Investments Management, LLC | Institution | 589 102 | 1,21% | US$ 253,31k | 2026-03-31 |
| Squadron Capital Management Llc | Institution | 563 535 | 1,16% | US$ 242,32k | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 516 218 | 1,06% | US$ 221,97k | 2026-03-31 |
| RA Capital Nexus Fund II, L.P. | Institution | 406 282 | 0,84% | US$ 174,70k | 2026-05-12 |
| Geode Capital Management, LLC | Institution | 389 487 | 0,80% | US$ 167,48k | 2026-03-31 |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | Institution | 241 034 | 0,50% | US$ 103,64k | 2026-03-31 |
| MPM Oncology Innovations Fund LP | Institution | 173 334 | 0,36% | US$ 74,53k | 2026-05-12 |
| Vanguard Fiduciary Trust Company | Institution | 157 726 | 0,32% | US$ 67,82k | 2026-03-31 |
| Millennium Management LLC | Institution | 132 050 | 0,27% | US$ 56,78k | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 119 168 | 0,25% | US$ 51,24k | 2026-03-31 |
| BlackRock, Inc. | Institution | 101 608 | 0,21% | US$ 43,69k | 2026-03-31 |
| Northern Trust Global Investments | Institution | 86 851 | 0,18% | US$ 37,35k | 2026-03-31 |
| Alyeska Investment Group, L.P. | Institution | 86 554 | 0,18% | US$ 37,22k | 2026-03-31 |
| Jane Street Group, LLC | Institution | 82 836 | 0,17% | US$ 35,62k | 2026-03-31 |
| Bridgeway Capital Management, LLC | Institution | 77 000 | 0,16% | US$ 33,11k | 2026-03-31 |
| BBVA Asset Management, S.A., S.G.I.I.C | Institution | 70 032 | 0,14% | US$ 30,11k | 2025-06-30 |
| UBS Asset Management AG | Institution | 66 857 | 0,14% | US$ 28,75k | 2026-03-31 |
| XTX Markets Limited | Institution | 50 929 | 0,10% | US$ 21,90k | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 38 266 | 0,08% | US$ 16,45k | 2026-03-31 |
| Morgan Stanley | Institution | 33 799 | 0,07% | US$ 14,53k | 2026-03-31 |
| Simplex Trading, LLC | Institution | 32 526 | 0,07% | US$ 13,99k | 2026-03-31 |
| Verdad Advisers, L.P. | Institution | 29 760 | 0,06% | US$ 12,80k | 2026-03-31 |
| MPM BioVentures IV, L.P. | Institution | 27 267 | 0,06% | US$ 11,72k | 2026-05-12 |
| Bank of America Corporation | Institution | 23 549 | 0,05% | US$ 10,13k | 2026-03-31 |
| Raymond James Financial, Inc. | Institution | 19 778 | 0,04% | US$ 8,50k | 2026-03-31 |
| Hudson River Trading LLC | Institution | 17 861 | 0,04% | US$ 7,68k | 2026-03-31 |
| Dr. Briggs Duncan W. Morrison | Initiés | 15 523 | 0,03% | US$ 6,67k | 2025-04-14 |
| Certuity, LLC | Institution | 15 000 | 0,03% | US$ 6,45k | 2026-03-31 |
| Delta Investment Management, LLC | Institution | 14 925 | 0,03% | US$ 6,42k | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
